Popular terms

Anesthetic topics
Anesthetic
Anesthesia
Anesthetics
Pharmaceutically Acceptable Salt
Drug Delivery System
Local Anesthesia
Phase Shift
Phase Change Material
Evaporation
Motor Function
Acute Pain
Ultrasound
Physiological Conditions
Physiologic
Cosmetic Procedure

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Anesthetic patents



      

This page is updated frequently with new Anesthetic-related patent applications.




Date/App# patent app List of recent Anesthetic-related patents
02/04/16
20160030723 
 Multi-chamber anesthetic delivery system patent thumbnailMulti-chamber anesthetic delivery system
The present invention is directed to a multi-chamber delivery system of a topical anesthetic formulation for improving the stability of such anesthetic compositions. Topical anesthetics formulations have long been used for providing analgesia prior to any invasive medical procedure.
Lannett Company, Inc.


02/04/16
20160030472 
 Xenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery patent thumbnailXenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery
A xenon-based anesthetic gas to be used, via inhalation, to maintain or preserve cerebral perfusion during an endarterectomy involving the clamping of the carotid artery in a mammal under general anesthesia. The xenon is preferably used in combination with at least one injectable anesthetic morphine agent such as remifentanil, sulfentanil, fentanyl, and alfentanil.
Air Liquide Santé (international)


02/04/16
20160030409 
 Method for relieving chronic pain patent thumbnailMethod for relieving chronic pain
The method is for use in a part of a mammal having one or more tender points and comprises a dministering a fluid, by a needleless, pressure-based injector, to substantially all of the tender points in the part. The volume of the fluid that is administered to each of the tender points can be about 0.5 cc.

02/04/16
20160029950 
 Method and  measuring anesthetic depth using cepstrum technique patent thumbnailMethod and measuring anesthetic depth using cepstrum technique
The present invention relates to a more accurate method for measuring anesthetic depth compared to existing methods for measuring anesthetic depth by using a cepstrum technique, thereby providing an anesthetic depth at an appropriate time even during sudden changes in anesthetic states. The method for measuring anesthetic depth using the cepstrum technique comprises the steps of: a first characteristic vector extraction portion receiving a first eeg signal as an input signal, calculating with a mel-frequency cepstral coefficient (mfcc), and extracting a first characteristic vector; a second characteristic vector extraction portion receiving, as input signals, a second eeg signal from an anesthetic state and a third eeg signal from a non-anesthetic state, calculating with the mel-frequency cepstral coefficient (mfcc), and extracting a second characteristic vector and a third characteristic vector; and a quantifying portion dividing, into a plurality of sections, an area between two axes of a vector flat surface having the second characteristic vector and the third characteristic vector as the two axes, and quantifying a position of the first characteristic vector within the plurality of sections to output an anesthetic depth index..
Charm Engineering Co., Ltd.


01/28/16
20160022676 
 Topical medications for bruises and burns patent thumbnailTopical medications for bruises and burns
Topical medications to treat the physical effects of bruises and burns. For bruises, the topical medication preferably includes therapeutically effective amounts of vasoconstrictor, such as phenylephrine hcl usp, an anti-inflammatory, such as arica, and compounding agents.
Meridian Research And Development, Inc.


01/21/16
20160015731 
 A topical antiviral composition containing a local anesthetic and  making the same patent thumbnailA topical antiviral composition containing a local anesthetic and making the same
The present invention provides a novel pharmaceutical composition and method of making the same. The composition comprises an effective amount of an antiviral agent and a local anesthetic.
Nal Pharmaceuticals, Ltd.


01/07/16
20160000672 
 Dermatological compositions and methods patent thumbnailDermatological compositions and methods
Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.. .
Upsher-smith Laboratories, Inc.


12/31/15
20150374947 
 Anesthetic breathing apparatus having volume reflector unit with controllable penetration patent thumbnailAnesthetic breathing apparatus having volume reflector unit with controllable penetration
An anesthetic breathing apparatus and system, having a patient circle system for re-breathing exhaled gases by a patient a volume reflector, a fresh gas delivery line, and a gas sensor unit arranged to measure a gas stream upstream a fresh gas connection and downstream said reflector unit. The gas sensor unit provides a signal for detection of a reflector driving gas (rdg) crossing over the volume reflector during inspiration based on at least one property of the gas stream measured by the gas sensor unit.
Maquet Critical Care Ab


12/31/15
20150374936 
 Pleural air leak test system patent thumbnailPleural air leak test system
Disclosed are methods, apparatus, and systems useful for detecting leaks in pleural tissue. Also disclosed are methods of detecting and sealing such leaks.
Neomend, Inc.


12/31/15
20150374645 
 Devices and methods for sustained treatment of bladder pain and irritative voiding patent thumbnailDevices and methods for sustained treatment of bladder pain and irritative voiding
Devices and methods are provided for treating a patient having bladder pain and/or irritative voiding symptoms. The method includes administering to the patient's bladder lidocaine or another anesthetic agent continuously over a treatment period of 24 hours or more in an amount effective to achieve a therapeutic effect which is sustained beyond the end of the treatment period..
Allergan, Inc.


12/31/15
20150374285 

Method and measuring anesthetic depth


The present invention rapidly reacts to changes in the degree of anesthesia to provide an accurate and timely anesthetic depth measurement result, and a method for measuring anesthetic depth comprises the steps of: an epoch dividing portion generating an epoch signal by dividing a eeg signal into a plurality of numbers based on time units, a coefficient portion extracting a cai calculation value (cai) by calculating the number of points in an epoch having a value higher than an established critical value, a shannon entropy calculating portion extracting a shannon entropy calculation value (shen) by conducting a shannon entropy-calculation from the eeg signal, and a spectra entropy calculating portion extracting a spectra entropy value (spen) by conducting a spectra entropy calculation; an improved shannon entropy extracting portion extracting an improved shannon entropy calculation value (mshen) by multiplying the shannon entropy calculation value (shen) and the spectra entropy calculation value (spen); and a cai extracting portion extracting an anesthetic depth index (mscai) through logical operating of the improved shannon entropy calculation value(mshen) and the cai calculation value (cai).. .
Charm Engineering Co., Ltd.


12/24/15
20150366967 

Injectable long-acting local anesthetic semi-solid formulations and its compositions


What is disclosed is a semi-solid controlled release pharmaceutical composition containing biocompatible and bioerodible semi-solid lipid matrix incorporating local anesthetics agents to form a semi-solid solution, a method of using the pharmaceutical composition to treat, and a method of making the pharmaceutical composition.. .
Mira Pharma Corporation


12/17/15
20150359816 

Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer


Improved methods for preparing compositions including a heparinoid, an acute-acting anesthetic, and a buffer are described. These methods result in compositions in which the heparinoid and the acute-acting anesthetic are at least 90% stable for one year.
Urigen Pharmaceuticals, Inc.


12/17/15
20150359768 

Composition and compounded therapy


A compounded transdermal cream for the topical administration of a compounded therapy includes a first active agent selected from the group consisting of nabumetone in an amount between approximately 5.0% and approximately 25% by weight of the transdermal cream and amitriptyline in an amount between approximately 0.5% and approximately 4.0% by weight of the transdermal cream; a second active agent comprising a nerve depressant in an amount between approximately 5.0% and 15.0% by weight of the transdermal cream, wherein the nerve depressant is gabapentin; a third active agent comprising a local anesthetic in an amount between approximately 1.0% and approximately 7.0% by weight of the transdermal cream, wherein the local anesthetic comprises lidocaine and prilocaine; and dimethyl sulfoxide (dmso).. .
Cmpd Licensing, Llc


12/17/15
20150359767 

Composition and compounded therapy


A compounded transdermal cream for topical administration of a compounded therapy includes a nerve depressant such as gabapentin in an amount between approximately 5% and 15% by weight of the transdermal cream, an nsaid (non-steroidal anti-inflammatory drug) such as nabumetone in an amount between approximately 5% and approximately 25% by weight of the transdermal cream, a tricyclic antidepressant such as amitriptyline in an amount between approximately 0.5% and approximately 4% by weight of the transdermal cream, a local anesthetic such as lidocaine and prilocaine in an amount between approximately 1% and approximately 7% by weight of the transdermal cream, and dimethyl sulfoxide (dmso).. .
Cmpd Licensing, Llc


12/17/15
20150359738 

Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof


Provided herein are methods of locally and specifically anesthetizing nerve tissue in the trigeminal nerve pathway and methods of performing a surgical procedure on a subject in need thereof that include intranasally administering (1) a pharmaceutical composition that includes a local anesthetic agent and a mucosal absorption enhancer to a subject in need thereof, where the local anesthetic agent and mucosal absorption enhancer are present in an amount sufficient to anesthetize nerve tissue in the trigeminal nerve pathway upon administration, or (2) a pharmaceutical composition that include a free-base form of a local anesthetic agent, where the free-base form of the local anesthetic agent is present in an amount sufficient to anesthetize nerve tissue in the trigeminal nerve pathway upon administration.. .
Loewi Llc


12/03/15
20150342986 

Compositions and methods for pain relief without numbness


Methods for providing post-operative pain control or relief, without a medically significant degree of numbness, to a patient are disclosed. Methods include, for example, administering bicarbonate to an area of a patient during a surgical or dental procedure, near completion of a surgical or dental procedure or immediately following a surgical or dental procedure, in an area previously administered or containing a regional or local anesthetic, in an amount sufficient to provide the patient with pain control or relief, without a medically significant degree of numbness, for a period of time after the surgical or dental procedure..

12/03/15
20150342699 

Video-guided chest tube insertion system


A chest tube placement apparatus is provided that has an elongate body with a rigid tip that is disposed within the interior of a flexible chest tube and an inflatable member mounted to the body is inflated and the apparatus is then inserted in a prepared location in the chest wall of a patient. The body of the apparatus has at least one axial material transfer channel with a tip port that permits the injection of anesthetic or the aspiration of gases or liquids at the tip.
The Regents Of The University Of California


11/19/15
20150328427 

Pulse-width modulation controlling oxygen concentration in anesthetic machine or ventilator


A pulse-width modulation method for controlling oxygen concentration in an anesthetic machine or in a ventilator, comprising the following steps: step a, with a predetermined time interval as one pulse interval, a processing unit divides a breathing cycle into multiple consecutive pulse intervals; step b, a data calculation unit calculates the average inspiratory flow in a certain time interval on the basis of inspiratory flows in one cycle that are detected by a detecting unit, and then calculates the average oxygen flow of this stage on the basis of the average inspiratory flow; and, step c, a control unit selects a solenoid valve and controls the opening and closing times thereof on the basis of the average oxygen flow as calculated in the previous step to implement control of the oxygen flow for each interval.. .
Beijing Aeonmed Co., Ltd.


11/19/15
20150328189 

Anesthetic compounds and related methods of use


Provided herein are compounds according to formula (i): provided herein is also a pharmaceutical composition comprising a compound according to formula (i) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.. .
The General Hospital Corporation


11/19/15
20150327968 

Fixing device for endotracheal intubation of rodents


A fixing device for endotracheal intubation of rodents is provided. The fixing device includes: a bed configured to place a rodent thereon; a support member attached to an upper end portion of the bed in a transversely movable manner and supporting a gas supply pipe through which an anesthetic gas is supplied to the nose of the rodent; and a fastening member configured to fix the support member to the upper end portion of the bed after an end portion of the gas supply pipe is aligned with the nose of the rodent..
Samsung Electronics Co., Ltd.


11/12/15
20150321770 

New method to prevent or stop an airplane from being hijacked and to minimize the effect of damage by using remote and wireless real-time monitoring and inhalational general anesthetic gases controlled from the ground (level)


A method to stop hijack of an airplane, installs video monitors, audio monitors and a gas delivery system in passenger cabins, a cockpit and needed places. The gas is inhalational general anesthetic which make people into a deep sleep.

11/12/15
20150320534 

Fixing device for inhalation anesthesia of rodents


A device for fixing a laboratory rodent for inhalation anesthesia includes: a body including a cavity into which at least a part of a rodent including the nose of the rodent is insertable; and a gas supply pipe inserted into the cavity for supplying an anesthetic gas to the rodent, the gas supply pipe including a fixing part on an end portion thereof for fixing incisors of the rodent and an opening formed at a position forward from the fixing part for discharging the anesthetic gas. Therefore, the position of the opening relatively to the nose of the rodent may be constantly maintained..
Samsung Electronics Co., Ltd.


11/05/15
20150315230 

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same


The present disclosure is generally directed to neuroactive 19-alkoxy-17-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
Washington University


11/05/15
20150313675 

System and device for a fully automated approach to facilitate stellate ganglion block or pulsed radiofrequency procedure for treating ptsd


A system and method to facilitate a stellate ganglion block or a pulsed radiofrequency procedure to treat post-traumatic stress disorder. The method can be fully automated and guided by a computer or the process can be guided by the surgeon.

10/29/15
20150306339 

Safety system for a breathing delivering an anesthetic agent


A safety system for a breathing apparatus for delivery of an anesthetic agent having an anesthetic agent vaporizer having a reservoir for containing a liquid anesthetic agent has a reservoir for containing a liquid medical agent, a port for filling the reservoir with the liquid anesthetic agent, and a sensor device for sensing a filling action of the port. A change of position of a lid covering the port is can be detected, or insertion of a fill vessel into said the port is can be detected.
Maquet Critical Care Ab


10/22/15
20150297857 

Regulation of delivery of multiple anesthetic agents to a patient from an anesthetic breathing apparatus


In a method and system of regulating multiple anesthetic agents in a breathing circuit of an anesthetic breathing apparatus is disclosed, a primary anesthetic agent added to the breathing circuit is regulated to a set desired value of the amount of the primary anesthetic agent, and a secondary anesthetic agent in the breathing circuit is regulated to an amount of said secondary anesthetic agent that it is equal to or less than a defined threshold level, e.g. Of the concentration, of the secondary anesthetic agent..
Maquet Critical Care Ab


10/22/15
20150297790 

Hyaluronic acid-based gels including lidocaine


Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine.
Allergan Industrie Sas


10/22/15
20150297729 

Long-acting polymeric delivery systems


Compositions comprised of a delivery vehicle or delivery system and an active agent dispersed within the delivery vehicle or system, wherein the delivery vehicle or system contains a polyorthoester polymer and a polar aprotic solvent. Also disclosed are low viscosity delivery systems for administration of active agents.
Heron Therapeutics, Inc.


10/22/15
20150297718 

Iontophoresis delivery of cationic prodrugs for topical treatment of musculoskeletal or skin diseases


The present invention provides a method for topical delivery of pharmacologically active chemicals into local tissues (skin, subcutaneous, muscle and joint tissues) via the administration of their specially designed cationic prodrugs with anode iontophoresis. The pharmacologically active chemicals are either negatively charged or neutral under the physiologic ph, which are not suitable to be delivered with the anode iontophoresis.

10/22/15
20150297661 

Analgesic compositions and methods of use


The invention relates to the fields of pharmacology and medicine, and provides anesthetic compositions and methods for the treatment of pain using compositions comprising tea tree oil and one or more additional agent. The invention relates to analgesic compositions for the treatment of pain associated with a variety of disorders or conditions, particularly oral or dental disorders or conditions such as alveolar osteitis or dental caries..

10/22/15
20150297550 

Sustained release of topical anesthetics


A composition and method to alleviate oral mucosal discomfort and irritation in an orthodontic patient. A wax matrix containing less that 15% analgesic/anesthetic agent such as benzocaine and excipients enhanced and extended release of the analgesic/anesthetic agent compared to known art formulations.
University Of Kentucky Research Foundation


10/22/15
20150297517 

New stable anesthetic composition for reducing skin reactions


A composition is described with reduced degradation rate and/or improved stability of its components. The composition can alleviate or even annihilate cutaneous reactions and can include an emulsion with an oil phase and an aqueous phase, wherein the oil phase can be a eutectic mixture of at least one anesthetic compound and at least one adrenergic receptor agonist.
Galderma Research & Development


10/01/15
20150272875 

Alprostadil for treatment of premature ejaculation


Compositions and methods for the treatment of premature ejaculation are provided wherein a composition comprising a topical anesthetic, a shear-thinning polymeric thickener, a lipophilic component that is selected from the group consisting of an aliphatic c1 to c8 alcohol, an aliphatic c8 to c30 ester, a liquid polyol and a mixture thereof, water and a buffer system that provides a buffered ph value for the composition in the range of about 3 to about 7.4 is administered to the penile meatus.. .
Nexmed Holdings, Inc.


09/17/15
20150259376 

Neuroactive 19-alkoxy-17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same


The present disclosure is generally directed to neuroactive 19-alkoxy-17(20)-z-vinylcyano-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
Washington University


09/10/15
20150250745 

Formulation for the treatment of pain


Formulations and methods are provided for the treatment of pain, and neuropathic pain in particular. The formulations are eutectic mixtures of a capsaicinoid and a local anesthetic agent and/or an anti-pruritic agent..
Acorda Therapeutics, Inc.


09/10/15
20150250724 

Long-lasting, controlled-release local anesthetic liposome preparation


A long-lasting, controlled-release local anesthetic liposome preparation is produced by: providing a liposome composition, which is obtained by mixing, in a water-miscible organic solvent, a first aqueous phase solution with a water-miscible organic solution, in which a phospholipid and cholesterol are contained at a defined total concentration, at a defined ratio by volume thereby obtaining an emulsion wherein a total concentration of the phospholipid and cholesterol in the mixed phase is at 15 w/v % to 50 w/v %, followed by subjecting the emulsion to external solution exchange with a second aqueous phase solution to obtain a liposome composition wherein an ion gradient is formed between an internal-region aqueous phase of a liposome membrane made of the first aqueous phase solution and an external-region aqueous phase of the liposome membrane made of the second aqueous phase solution; and encapsulating a local anesthetic in the internal-region aqueous phase according to a remote loading method.. .
Terumo Kabushiki Kaisha


09/03/15
20150246089 

Skin sensitizer delivery system


A skin-sensitizing formulation is provided in an edible, softgel pill. A person engaged in a sexual activity bites down on the pill, thereby effectuating the oral release of the skin-sensitizing formulation.

08/27/15
20150238702 

Buffering agent delivery system for anesthetic system


A syringe for dispensing anesthetic from a cartridge having an interior wall defining a hollow interior sized and shaped for receiving a dose of anesthetic, and a piston. The syringe includes a tubular plunger slidably received in the hollow interior of the tubular cartridge.
Covidien Lp


08/27/15
20150238606 

Pharmaceutical composition containing luliconazole


Means for controlling the formation amount of a formed amide form in relation to a pharmaceutical composition containing luliconazole is provided. Disclosed is a pharmaceutical composition containing 1) luliconazole and 2) one component or two or more components selected from carboxylic acid and derivative thereof, ketone, phosphoric acid and derivative thereof, local anesthetic, antihistamine, and poe-based nonionic surfactant; wherein a content of an amide derivative of luliconazole is not more than 0.2% by mass with respect to a charged amount of luliconazole after storage at 60° c.
Nihon Nohyaku Co., Ltd.,


08/13/15
20150224093 

Kits and methods for treating post traumatic stress disorder (ptsd) and hot flashes


The present invention is directed to kits and methods for the treatment of a patient suffering from post-traumatic stress disorder (ptsd) and/or hot flashes by an administration of a mixture produced by a combination of a long acting local anesthetic combined with clonidine. The combination of the two pharmaceuticals produces a significant increase in duration and speed of onset of sympathetic blockade, increased intensity of the sympathetic blockage as well as the reduction of local anesthetic absorption locally.

08/06/15
20150217080 

Vaporizer filler and filling a vaporizer


A vaporizer filler includes a fill port. The fill port defines an open interior.
General Electric Company


08/06/15
20150216815 

Dermal pain relief delivery system


An easy to apply dermal delivery system embodying an apparatus and a method for relieving the localized discomfort caused by footwear is provided. The delivery system may include a generally planar base, adhesive layer and delivery apparatus.

07/30/15
20150209546 

Anesthesia machine


Disclosed is an anesthesia gas delivery device and methods of use therefor. The device comprises an aluminum cover plate, a gas inlet for a carrier gas, a gas outlet for a diluent anesthetic gas, a gas corridor in fluid communication with and extending between the gas inlet and the gas outlet, at least four ultrasound acoustic sensors, at least 2 thermistors, a reservoir comprising a reservoir housing for a liquid inhalational anesthetic, a controller, a graphical user interface, and means for transferring a sample of a liquid inhalational anesthetic from the reservoir to the gas corridor.
Portable Anesthesia Solutions Llc


07/30/15
20150209529 

Medication delivery apparatus and accompanying system for the application of local anesthetics to a treatment site and use of same


A medication delivery apparatus and system for the application of a local anesthetic to a treatment site, such as an airway, and method for use of same are disclosed. In one embodiment of the medication delivery apparatus and system, a reservoir supplies a local anesthetic to a lower chamber of a housing wherein an ultrasonic transducer applies ultrasonic energy thereto, thereby nebulizing the local anesthetic.
Dualams, Llc


07/30/15
20150209520 

Articulating applicators/injectors for administration of liquid anesthetic and other liquids


Disclosed are applicators and methods for injecting a liquid, such as anesthetic, into a patient with no or minimal pain. The applicator includes a coupling and a blade rotatably mounted on the coupling.

07/30/15
20150209238 

Nipple cover


One aspect of the present invention relates to a covering member for a protruding portion of a patient's body. This cover is flexible and collapsible so that it conforms to the shape of the encased portion of the body.
Dr. Susan Love Research Foundation


07/30/15
20150208940 

Non-stationary feature relationship parameters for awareness monitoring


Methods and systems are presented for determining physiological information in a physiological monitor. A physiological signal (e.g., an eeg signal) received from a subject is wavelet transformed and first and second related features that vary in scale over time are identified in the transformed signal.
Covidien Lp


07/23/15
20150203476 

Anesthetic compounds and related methods of use


Provided herein are compounds according to formula (i): provided herein is also a pharmaceutical composition comprising a compound according to formula (i) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.. .
Annovation Biopharma, Llc.


07/16/15
20150196542 

Kits and methods for treating post traumatic stress disorder (ptsd) and hot flashes


The present invention is directed to kits and methods for the treatment of a patient suffering from post-traumatic stress disorder (ptsd) and/or hot flashes by an administration of a mixture produced by a combination of a long acting local anesthetic combined with clonidine. The combination of the two pharmaceuticals produces a significant increase in duration and speed of onset of sympathetic blockade, increased intensity of the sympathetic blockage as well as the reduction of local anesthetic absorption locally.

07/09/15
20150190383 

Hair care composition with analgesic


A hair detangling composition includes a conditioning material, a lubricant, a scent, and an anesthetic.. .

07/09/15
20150190347 

Solid drug tablets for implantable drug delivery devices


A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof.
Taris Biomedical Llc


07/02/15
20150182538 

Silicone-based composition for skin treatment


The present embodiments may relate to topically delivered compounded medications for the treatment of scar tissue, skin disorders, and/or other ailments. In one aspect, a transdermal cream or gel may provide for the effective administration of multiple medications simultaneously.
Cmpd Licensing, Llc


07/02/15
20150182536 

Tumescent antibiotic solution


Disclosed herein are solutions and kits for tumescent antibiotic delivery. Embodiments of the solution comprise an antibiotic component, an anesthetic component and a vasoconstrictor component.

07/02/15
20150182512 

Methods and compositions for treating infections comprising a local anesthetic


The present invention is directed to a drug depot useful for reducing, preventing or treating an infection in a patient in need of such treatment. The drug depot includes a polymer and a therapeutically effective amount of a local anesthetic or pharmaceutically acceptable salt thereof.
Warsaw Orthopedic, Inc.


06/25/15
20150174388 

Methods and systems for ultrasound assisted delivery of a medicant to tissue


This disclosure provides methods and systems for ultrasound assisted delivery of a medicant to tissue. The delivery of the medicant is enhanced by the application of high intensity ultrasound pulses, which generate an intertial cavitation effect, an acoustic streaming effect, or both.
Guided Therapy Systems, Llc


06/18/15
20150165224 

Treatment of thalamocortical dysrhythmia


A method for treating conditions associated with thalamocortical dysrhythmia. The method includes applying transcranial low voltage electrical stimulation (tlves) therapy or transcranial magnetic stimulation (tms) therapy to a patient in need thereof, and administering to the patient a dissociative anesthetic during the tlves therapy or the tms therapy.

06/18/15
20150165136 

Medicament delivery system having a selectable delivery spray pattern and a its use


Provided herein are medicament delivery systems for selectively providing radial, distal, or a combination radial and distal delivery spray patterns of a medicament, and a method of their use to treat a patient's airway. Generally, a medicament delivery system comprises an elongate shaft, a medicament source, and a means for controlling the delivery spray pattern of the elongate shaft.
Stela Medical, Llc


06/18/15
20150165124 

Syringe carpule for storing, transporting and in situ mixing of local anesthetic and buffer, and for delivery of buffered anesthetic solution and a piercing-mixing unit therefore


A syringe carpule for storing, transporting and in situ mixing of a local anesthetic, such as lidocaine, and a buffer, such as sodium bicarbonate, and delivery of buffered anesthetic solution comprises a hollow tubular body received within the frame of a carpule syringe, at least one axially movable plunger within the body and configured to be engaged and moved by a rod of the carpule syringe, a seal pierced by a rear portion of a needle coupled to the carpule syringe, a first chamber within the body filled with anesthetic solution during storing and transport, a second chamber defined within the body filled with buffering solution during storing and transport; and a breachable separating member between the first and second chamber configured to be removed by a piercing-mixing unit for in situ mixing of the buffering and the anesthetic solutions allowing for delivery of a buffered anesthetic solution.. .

06/18/15
20150164485 

Dna medicated collection kits


Provided are kits for collecting samples from a person for dna (deoxyribonucleic acid) testing. The kits can optionally also allow for collection of a urine sample.
Asclemed Usa, Inc. Dba Enovachem Manufacturing


06/18/15
20150164413 

Method of creating anesthetic consciousness index with artificial neural network


A method of creating an anesthetic consciousness index with an artificial neural network includes, obtaining physiological signals, including electroencephalographic signals and eye movement signals, from subjects during a physiological signal monitoring process; filtering noise out of the physiological signals by empirical mode decomposition (emd); calculating sample entropy values of the noise-removed physiological signals; obtaining sample entropy value sets of the physiological signals; repeating the aforesaid steps to effectuate measurement, noise-filtering, and sample entropy value calculation of the subjects' physiological signals and thus obtain a sample entropy value set; and applying an artificial neural network in conducting regression analysis of the sample entropy value set and a set of levels of consciousness measured with a physiological signal monitor during the physiological signal monitoring process, thereby creating the anesthetic consciousness index model for evaluating the level of consciousness of an anesthetized patient during the physiological signal monitoring process.. .
National Chung Shan Institute Of Science And Technology


06/18/15
20150164412 

Point of care measurement of patient sensitivity to anesthetics


A method and system for monitoring a patient under anesthesia involves determining a drug sensitivity index for the patient. Patient demographic information and amount of anesthetic information is obtained, wherein the amount of anesthetic information includes each drug administered to the patient and the dose amount thereof.
General Electric Company




Anesthetic topics: Anesthetic, Anesthesia, Anesthetics, Pharmaceutically Acceptable Salt, Drug Delivery System, Local Anesthesia, Phase Shift, Phase Change Material, Evaporation, Motor Function, Acute Pain, Ultrasound, Physiological Conditions, Physiologic, Cosmetic Procedure

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Anesthetic for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Anesthetic with additional patents listed. Browse our RSS directory or Search for other possible listings.


1.0001

4826

2 - 1 - 101